They can state that glutathione 'supports antioxidant activity' or 'promotes cellular health' because those are structure-function claims permitted under 21 CFR 101.93
The treatment carries certain risks, such as allergic reactions, kidney or thyroid damage, infections, ochronosis, and toxicity
Novo Nordisks CagriSema Shows Strong Weight-Loss Results But Trails Eli Lillys Tirzepatide in Latest Clinical Data Feb 26, 2026 A New Chapter in the Global Anti-Obesity Drug Race The competition to develop next-generation obesity therapies intensified following the release of new Phase III clinical data for CagriSema, an investigational drug from Novo Nordisk
The goal of fish nutritionists is to invoke effective nutritional regulating pathways with lipid-lowering effects, especially through enhancing lipid catabolism
Oleksiak MF, Churchill GA, Crawford DL